3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 1
3
Phase NA
1
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Breast Neoplasms
107
Neoplasms
91
Prostatic Neoplasms
51
Lung Neoplasms
51
Colorectal Neoplasms
47
Motor Activity
23
Uterine Cervical Neoplasms
22
Pancreatic Neoplasms
21
Brain Neoplasms
20
Ovarian Neoplasms
19
Carcinoma, Hepatocellular
15
Head and Neck Neoplasms
14
Glioblastoma
14
Stomach Neoplasms
13
Rectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Multiple Myeloma
11
Leukemia
11
Hematologic Neoplasms
11
Glioma
11
Disease
11
Depression
11
Colonic Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Papillomavirus Infections
9
Anxiety Disorders
9
Melanoma
8
Sarcoma
7
Lymphoma
7
Liver Neoplasms
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Neuroendocrine
×
30 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled